Hypercalcemia in Active Pulmonary Tuberculosis

  1. ALI A. ABBASI, M.D.;
  2. JOSEPH K. CHEMPLAVIL, M.D.;
  3. FARAH SAMIR, M.D.;
  4. BERNHARD F. MULLER, M.D.; and
  5. A. ROBERT ARNSTEIN, M.D.
  1. Allen Park, Detroit, and Royal Oak, Michigan

    Abstract

    We ascertained the incidence of hypercalcemia in 79 consecutive patients with active pulmonary tuberculosis and a control group of 79 patients with chronic obstructive pulmonary disease. Twenty-two patients developed hypercalcemia (serum calcium greater than 10.5 mg/dl) within 4 to 16 weeks after initiation of chemotherapy for tuberculosis. The duration of hypercalcemia ranged from 1 to 7 months, and remission occurred spontaneously in all patients. The mean daily vitamin D supplement was greater in hypercalcemic patients than in the normocalcemic group. There was a positive correlation between daily vitamin D supplement and degree and duration of hypercalcemia. Mean serum calcium in patients with tuberculosis was higher than in patients with chronic obstructive pulmonary disease supplemented with the same dose of vitamin D. Hypercalcemia appears to be related to the activity of pulmonary tuberculosis and the intake of vitamin D; the exact mechanism, however, remains unknown.

    Article and Author Information

    • ▸From the Veterans Administration Hospital, Allen Park, the Department of Medicine, Wayne State University School of Medicine, Detroit, and William Beaumont Hospital, Royal Oak, Michigan.

    • ▸Requests for reprints should be addressed to Ali A. Abbasi, M.D.; Veterans Administration Medical Center; Allen Park, MI 48101.

      • Received June 21, 1978.
      • Accepted November 22, 1978.
    « Previous | Next Article »Table of Contents